Kangji Medical Holdings Limited
SZSC:9997 株式レポート
Kangji Medical Holdings 過去の業績 Kangji Medical Holdingsは、平均年間21.5%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間14.7% 15.5%収益成長率で 成長しています。 Kangji Medical Holdingsの自己資本利益率は21.1%であり、純利益率は54.5%です。
主要情報 Medical Equipment 業界の成長 13.7% 収益成長率 15.5% 株主資本利益率 21.1% ネット・マージン 54.5% 前回の決算情報 30 Jun 2024
最近の業績更新
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
すべての更新を表示
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06 Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024
Investor sentiment deteriorates as stock falls 26% May 29
Upcoming dividend of CN¥1.40 per share May 22
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 Apr 26
Dividend of CN¥1.40 announced Mar 22 Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024
Investor sentiment improves as stock rises 17% Nov 08
Kangji Medical Holdings Limited Announces CFO Changes Sep 06 Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
Now 21% undervalued after recent price drop Aug 01
Now 22% undervalued after recent price drop Jul 05
Now 20% undervalued after recent price drop Jun 12
Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023 May 26
Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021) Mar 29
Investor sentiment improved over the past week Jan 16
Less than half of directors are independent Nov 16
First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022 Aug 03
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022 May 27
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021 May 26
Upcoming dividend of HK$0.17 per share May 20
Kangji Medical Holdings Limited Announces Executive Changes May 04
Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020) May 03
Less than half of directors are independent Apr 27
Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022 Mar 03
Investor sentiment deteriorated over the past week Dec 07
Investor sentiment improved over the past week Sep 02
First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020) Aug 29
Investor sentiment improved over the past week Aug 03
Investor sentiment improved over the past week Jul 16
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020 May 27
Investor sentiment improved over the past week May 17
Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.20 in FY 2019) Apr 28
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020 Apr 27
Investor sentiment improved over the past week Apr 24
Full year 2020 earnings released Mar 26
Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021 Mar 13
Investor sentiment deteriorated over the past week Feb 27
New 90-day low: HK$10.88 Feb 27
Investor sentiment deteriorated over the past week Jan 29
New 90-day low: HK$12.16 Jan 28
Investor sentiment deteriorated over the past week Dec 24
New 90-day low: HK$13.86 Dec 09
Market pulls back on stock over the past week Nov 26
Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director Nov 06
First half earnings released Sep 22
Kangji Medical Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史 SZSC:9997 収益、費用、利益 ( )CNY Millions 日付 収益 収益 G+A経費 研究開発費 30 Jun 24 981 534 181 111 31 Mar 24 953 519 176 119 31 Dec 23 926 504 171 128 30 Sep 23 892 540 158 114 30 Jun 23 858 576 146 100 31 Mar 23 822 528 135 83 31 Dec 22 786 479 124 66 30 Sep 22 745 447 122 56 30 Jun 22 704 415 120 46 31 Mar 22 697 436 115 41 31 Dec 21 690 457 109 36 30 Sep 21 654 413 103 33 30 Jun 21 617 369 96 29 31 Mar 21 564 310 95 27 31 Dec 20 511 250 95 25 30 Sep 20 506 227 88 23 30 Jun 20 500 204 81 21 31 Mar 20 502 205 74 19 31 Dec 19 503 206 67 17 31 Dec 18 354 147 43 15 31 Dec 17 248 118 29 10
質の高い収益: 9997は 高品質の収益 を持っています。
利益率の向上: 9997の現在の純 利益率 (54.5%)は、昨年(67.2%)よりも低くなっています。
過去の収益成長分析
収益動向: 9997の収益は過去 5 年間で年間21.5%増加しました。
成長の加速: 9997は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: 9997は過去 1 年間で収益成長率がマイナス ( -7.3% ) となったため、 Medical Equipment業界平均 ( -4.3% ) と比較することが困難です。
株主資本利益率
高いROE: 9997の 自己資本利益率 ( 21.1% ) は 高い とみなされます。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}